Last Name

Ioana Bica, MD

TitleAssistant Professor
InstitutionBoston University School of Medicine
DivisionInfectious Diseases
Address771 Albany St
Boston MA 02118
Phone(617) 414-5417
ORCID ORCID Icon0000-0001-9896-3021
Other Positions
TitleActive Staff Hospital Privileges
InstitutionBoston Medical Center

 Research Expertise & Professional Interests
Expertise includes: HIV infection; HCV-HIV Coinfection; Complementary and alternative therapies in HIV field.

 Self-Described Keywords
  • HCV
  • HIV
  • HIV-HCV coinfection
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Jarrett OD, Wanke CA, Ruthazer R, Bica I, Isaac R, Knox TA. Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus. AIDS Patient Care STDS. 2013 May; 27(5):266-71. PMID: 23651103.
    View in: PubMed
  2. McGovern BH, Birch C, Zaman MT, Bica I, Stone D, Quirk JR, Davis B, Zachary K, Basgoz N, Graeme-Cook F, Gandhi RT. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon. Clin Infect Dis. 2007 Nov 15; 45(10):1386-92. PMID: 17968840.
    View in: PubMed
  3. McGovern BH, Wurcel A, Kim AY, Schulze zur Wiesch J, Bica I, Zaman MT, Timm J, Walker BD, Lauer GM. Acute hepatitis C virus infection in incarcerated injection drug users. Clin Infect Dis. 2006 Jun 15; 42(12):1663-70. PMID: 16705568.
    View in: PubMed
  4. McGovern B, Fiore J, Wurcel A, Taglienti P, Bradley M, Galvin S, Libone G, Ramsey J, Molinaro-Gudas V, Drewniak S, Amick C, Andalkar A, Scheft H, Bica I. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients. Clin Infect Dis. 2005 Jul 1; 41 Suppl 1:S56-62. PMID: 16265615.
    View in: PubMed
  5. Mangili A, Bica I, Snydman DR, Hamer DH. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2005 Apr 1; 40(7):1058-60. PMID: 15825002.
    View in: PubMed
  6. Jacobson DL, Bica I, Knox TA, Wanke C, Tchetgen E, Spiegelman D, Silva M, Gorbach S, Wilson IB. Difficulty swallowing and lack of receipt of highly active antiretroviral therapy predict acute weight loss in human immunodeficiency virus disease. Clin Infect Dis. 2003 Nov 15; 37(10):1349-56. PMID: 14583869.
    View in: PubMed
  7. McGovern B, Bica I. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon? Clin Infect Dis. 2003 Aug 1; 37(3):463-4; author reply 464-5. PMID: 12884180.
    View in: PubMed
  8. Bica I, Tang AM, Skinner S, Spiegelman D, Knox T, Gorbach S, Wilson IB. Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy. J Altern Complement Med. 2003 Feb; 9(1):65-76. PMID: 12676036.
    View in: PubMed
  9. McGovern B, Bica I. Risk of HAART therapy in hepatitis C. Hepatology. 2002 Mar; 35(3):730. PMID: 11870393.
    View in: PubMed
  10. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001 Feb 1; 32(3):492-7. PMID: 11170959.
    View in: PubMed
  11. Bica I, Hamer DH, Stadecker MJ. Hepatic schistosomiasis. Infect Dis Clin North Am. 2000 Sep; 14(3):583-604, viii. PMID: 10987111.
    View in: PubMed
Ioana's Networks
Click the "See All" links for more information and interactive visualizations!
BU Co-Authors
Similar BU People
Same Department